Chemists Anxious About Discipline's Fate

Academic and industrial researchers hold differing views on whether--and how severely--the chemistry profession is suffering Talk to academic chemists these days and they're likely to tell you they're worried. The anxiety they feel doesn't concern a difficult experiment; rather, they fear for the future of their profession. They see fewer United States college students majoring in chemistry. But they also see diminishing quality in the current crop of doctorates. They see unfilled job open

Written byRobin Eisner
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

They worry that the U.S. will fail to attract the young scientific hopefuls needed to replace the chemists who will be either retired or deceased by the end of the 1990s; they add muscle to their warning with the prediction that if academic chemistry falls, so will American industry. They support their prognostications with the observation that America's chemical industry is one of few having a positive trade balance--$15.7 billion in 1989--in the world economy without the help of a government subsidy.

But this is the voice of the academic scientist. Talk to industrial chemists and you're likely to receive a different message. Yes, they are concerned about the quality of chemists coming out of the university. But many industrial chemists don't accept the negative prognostications of the academic chemists. And they suggest that even if the predictions come true, the industry can deal with the situation.

Year No. Ph.D. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies